ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Interactive Brokers

Interactive Brokers
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P 500
5,633.91
1.02%
US Tech 100
20,107.60
0.99%
Dow Jones
39,721.36
1.09%
Brent Oil
85.395
0.41%
Bitcoin
57,817.01
0.10%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. UK
  5. LSE

  6. Norman Broadbent Plc (NBB) Quote

Norman Broadbent Plc

Norman Broadbent Plc (NBB)

Nuveen Taxable Municipal Income Fund
6.50
-2.00
(-23.53%)
Closed July 11 11:30AM
Delayed by 15 minutes

Professional-Grade Tools, for Individual Investors.

Premium

Key stats and details

Current Price
6.50
Bid
6.00
Ask
7.00
Volume
371,513
6.50 Day's Range 8.50
4.30 52 Week Range 10.50
Market Cap
5.429M
Previous Close
8.50
Open
8.25
Last Trade
285568
@
6.15
(O)
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
35,730
Shares Outstanding
63,865,249
Dividend Yield
-
PE Ratio
13.54
Earnings Per Share (EPS)
-
Revenue
12.31M
Net Profit
309k

About Norman Broadbent Plc

Sector
Business Consulting Svcs,nec
Industry
Business Consulting Svcs,nec
Website
www.normanbroadbent.com
Headquarters
London, Gbr
Founded
1970
Norman Broadbent Plc is listed in the Business Consulting Svcs sector of the London Stock Exchange with ticker NBB. The last closing price for Norman Broadbent was 8.50p. Over the last year, Norman Broadbent shares have traded in a share price range of 4.30p to 10.50p.

Norman Broadbent currently has 63,865,249 shares outstanding. The market capitalization of Norman Broadbent is £5.43 million. Norman Broadbent has a price to earnings ratio (PE ratio) of 13.54.

NBB Latest News

More News

Norman Broadbent PLC Result of Annual General Meeting

Norman Broadbent PLC 23 May 2024   23 May 2024   Norman Broadbent plc ("Norman Broadbent", "NBB" or the "Company")   Result of Annual General Meeting   Norman Broadbent (AIM: NBB), a...

May 23 2024
RNS Regulatory News

Norman Broadbent emphasises strong second quarter as first disappoints

Norman Broadbent PLC on Thursday said that it remains confident in meeting its goals for the next financial year, des ...

April 25 2024
Alliance News

Norman Broadbent PLC Q1 2024 Trading Update

Norman Broadbent PLC 25 April 2024   25 April 2024   Norman Broadbent plc ("Norman Broadbent", "NBB" or the "Company")   Q1 2024 TRADING UPDATE   Norman Broadbent (AIM: NBB), a...

April 25 2024
RNS Regulatory News

Norman Broadbent PLC Small Cap Awards nomination

Norman Broadbent PLC 24 April 2024   RNS Reach 24 April 2024   Norman Broadbent plc ("Norman Broadbent", "NBB" or the "Company")   Small Cap Awards nomination for Diversity, Inclusivity &...

April 24 2024
RNS Non-Regulatory

Norman Broadbent PLC Notification of major holdings

Norman Broadbent PLC 15 April 2024   TR-1: Standard form for notification of major holdings 1. Issuer Details ISIN GB00B3VF4Y66 Issuer Name NORMAN BROADBENT PLC UK or Non-UK Issuer UK 2...

April 15 2024
RNS Regulatory News

Norman Broadbent PLC Issue of Equity and Total Voting Rights

Norman Broadbent PLC 08 April 2024   8 April 2024   Norman Broadbent plc (the "Company" or "Norman Broadbent")   Issue of Equity and Total Voting Rights   Norman Broadbent (AIM: NBB), a...

April 08 2024
RNS Regulatory News

Norman Broadbent PLC Notification of major holdings

Norman Broadbent PLC 03 April 2024   TR-1: Standard form for notification of major holdings 1. Issuer Details ISIN GB00B3VF4Y66 Issuer Name NORMAN BROADBENT PLC UK or Non-UK Issuer UK 2...

April 03 2024
RNS Regulatory News

Norman Broadbent PLC Posting of ARA & Notice of AGM

Norman Broadbent PLC 28 March 2024     28 March 2024   Norman Broadbent plc ("Norman Broadbent" or the "Company")   Posting of Annual Report and Accounts and Notice of Annual General Meeting...

March 28 2024
RNS Regulatory News

EARNINGS: Aurora hails AI potential; Technology Minerals optimistic

The following is a round-up of earnings by London-listed companies, issued on Wednesday and not separately reported b ...

March 27 2024
Alliance News
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10008.5000DE
4-2.625-28.76712328779.1259.1256.5338348.66625308DE
12-3.25-33.33333333339.759.756.5357309.12682917DE
26-0.75-10.34482758627.2510.56.5792988.4488913DE
52118.18181818185.510.54.3663987.55910071DE
156-1-13.33333333337.510.53.5933526.31196407DE
260-3-31.57894736849.510.753.51000376.61907431DE

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
KZIAKazia Therapeutics Ltd
$ 0.6509
(239.01%)
450.24M
IVPInspire Veterinary Partners Inc
$ 8.11
(130.40%)
29.26M
NBSTWNewbury Street Acquisition Corporation
$ 0.0998
(66.33%)
3.1k
CYCNCyclerion Therapeutics Inc
$ 3.81
(65.64%)
18.89k
CINGCingulate Inc
$ 0.5996
(61.05%)
1.24M
ZAPPZapp Electric Vehicles Group Ltd
$ 9.40
(-47.63%)
9.97M
SISIShineco Inc
$ 2.49
(-44.79%)
1.59M
CVRXCVRx Inc
$ 7.18
(-38.26%)
2.04M
ICUSeaStar Medical Holding Corporation
$ 8.07
(-37.92%)
1.12M
TOIIWOncology Institute Inc
$ 0.0185
(-31.23%)
2.57k
KZIAKazia Therapeutics Ltd
$ 0.6509
(239.01%)
450.24M
NVDANVIDIA Corporation
$ 134.91
(2.69%)
248.96M
MAXNMaxeon Solar Technologies Ltd
$ 0.2078
(-16.21%)
246.5M
TSLATesla Inc
$ 263.26
(0.35%)
128.52M
VRPXVirpax Pharmaceuticals Inc
$ 1.68
(44.83%)
117.18M

Discussion

View Full Feed
janice shell janice shell 5 minutes ago
OH! You're so nieve!

So what? If you're going to accuse others here of being naive, you'd better learn to spell it correctly.
doc063 doc063 10 minutes ago
I'm seeing all of the attention on RNVA and not FOXO on IHub.

Something to make us all think about what's cooking in the background.
FOXO RNVA
somberfox somberfox 10 minutes ago
Nah man, we're gonna get a watch, you know, the thing that's never used in 2024, save for Garmins/fitbits.
RONN
Lazarus Lazarus 11 minutes ago
Just dropped in to make sure you're still holdin' down the fort here.

This from the book of Ecclesiasticus [chapter 38]:

Honour a physician with the honour due unto him for the uses which ye may have of him: for the Lord hath created him.

For of the most
chereb19 chereb19 11 minutes ago
Direct Interstitial Injection: An Approach to Optimizing Therapeutic Ratios for Safe and Effective Delivery of High-dose Radionuclide Therapy in Treating Solid Tumors (P446)
Mon, July 08
Gatlin C/D
Poster Session

Part of:
Poster Session 1
Info
RDGL
LetGoodTimesRoll LetGoodTimesRoll 12 minutes ago
$RNVA==>$FOXO ===>NYSE====>$$$$$$$
FOXO RNVA
GoodGuyBill GoodGuyBill 13 minutes ago
And your comment... ROTFLMAO!!!!

Your entire comment is simply no more than a speculative wish list, akin to a child writing to santa, in the hope of getting a new bike 🚲 ☝️🥴
NWBO
Lazarus Lazarus 16 minutes ago
oops / duplicate
Lazarus Lazarus 16 minutes ago
My late brother had a RX filled incorrectly and I think he had a bad reaction. I'm not sure who his attorney sued - doctor or pharmacist - but he got something like $30k as a result. This was around 45 years ago
Vexari Vexari 17 minutes ago
The cartel

Has no remorse
janice shell janice shell 17 minutes ago
Does anyone know what really happened during Donald Trumps trial?

You really are a dimwit. A dimwit without a television, it seems. All the networks had people in the courtroom transcribing what happened at the trial. And yes, there was an official steno, who produced official transcr
littlejohn littlejohn 18 minutes ago
TSLA - China - bicycles - rising EV sales

by China companies in 2024 are

still putting margin pressure on TSLA...

Bicycles are still owned by most China

folks in case the power goes out,

so the EVs adapting better in China ar
SQQQ TSLA
BDEZ BDEZ 23 minutes ago
TX moves to ban Sharia Law

https://x.com/FarmGirlCarrie/status/1811134301075013781
mikepgator mikepgator 26 minutes ago
Wow nice last minute of trading!
RDGL
Lazarus Lazarus 27 minutes ago
RE: > perhaps...
ooooooh. you dont say?
RJDG
ATLnsider ATLnsider 28 minutes ago
meirluc, I respect your opinion, but I still disagree that there would be any need or added benefit to add SurVaxM to DCVax-L.

DCVax-L already targets survivin, plus hundreds of other antigens, peptides and biomarkers. I will stick with what Dr. Linda Liau and Dr. Robert Prins study r
NWBO
BDEZ BDEZ 30 minutes ago
Welfare costs exploding in Germany

https://x.com/ramzpaul/status/1811041484558283128

Sound familiar?
XMaster2023 XMaster2023 30 minutes ago
Pump, this is small PRE revenue biotech firm. DCVax-L will be their ONLY approved product. What the hell did you expect? Blood from a turnip?
This said approval and revenue are just around the corner. Your boss can shove it!
NWBO
F4Uvet F4Uvet 31 minutes ago
Bravery has nothing to do with the barking dog. The dog was only voicing his opinion regarding the stupidity of the lion's death which was the result of his overwhelming avarice.
MXSG
Tadaaa Tadaaa 36 minutes ago
The enemy does their best work in the Principalities:

-Education
-Politics
-Religion
-Economics
-Propaganda

We war not against flesh and blood but against spiritual wickedness in high places.

Researchfyi Researchfyi 38 minutes ago
Many consumers own smart watches and other smart products used for health related tracking. But, ironically none of them unless used for a specific function like diabetes have FDA approval.

I believe FDA approval for the purposes of sales is a very strategic competitive factor and hug
LQMT
rooster rooster 38 minutes ago
I’m a mechanical contractor who only installs new plumbing and hvac systems
ducci1 ducci1 38 minutes ago
Pivot Calcs: SPX Pivot--5618----R1--5651----R2--5667----R3--5700-----S1--5602----S2--5569----S3--5552 !
SPY

Your Recent History

LSE
NBB
Norman Broadbent
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

United States
Company
Business
Popular
Get The App
App Store
Google Play

Support: 1-888-992-3836 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved